Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Stanford University
Stanford University
Washington University School of Medicine
IRCCS Azienda Ospedaliero-Universitaria di Bologna
University of Chicago
Grupo Espanol de Tumores Neuroendocrinos
Jonsson Comprehensive Cancer Center
Gustave Roussy, Cancer Campus, Grand Paris
Minia University
Università Cattolica di Milano
M.D. Anderson Cancer Center
Fudan University
Fudan University
Fudan University
Ankara University
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Kaiser Permanente
Sichuan Enray Pharmaceutical Sciences Company
South Egypt Cancer Institute
City of Hope Medical Center
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Fujian Medical University
University of Michigan Rogel Cancer Center
The First Affiliated Hospital of Xiamen University
University of Auckland, New Zealand
University Medical Center Groningen
Institut du Cancer de Montpellier - Val d'Aurelle
Jonsson Comprehensive Cancer Center
University of Colorado, Denver
Hospices Civils de Lyon
Alliance for Clinical Trials in Oncology
Assiut University
The Cleveland Clinic
Rigshospitalet, Denmark
Memorial Sloan Kettering Cancer Center
Fred Hutchinson Cancer Center
University of Nebraska
Zhejiang University
Georgetown University
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Georgetown University
Memorial Sloan Kettering Cancer Center
University of California, San Francisco
Brigham and Women's Hospital
Stanford University
Second Affiliated Hospital of Nanchang University
Second Affiliated Hospital, School of Medicine, Zhejiang University
Udayana University
Memorial Sloan Kettering Cancer Center